Japanese approval for St Jude's Genesis pain relief device
This article was originally published in Clinica
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved St Jude Medical's Genesis neurostimulation system. It is now available in Japan for the management of chronic pain of the limbs and trunk, including that caused by failed back surgeries. Genesis is a small implanted device that delivers mild electrical pulses via leads placed near the spinal cord, which are thought to interrupt pain signals to the brain. The device is also approved in the US, Canada, Australia, certain Latin American and Asian markets, including China, and is CE marked for sale in Europe. It is similar to the St Paul, Minnesota company's Eon and Eon Mini neurostimulators but, unlike them, is not rechargeable.